130 related articles for article (PubMed ID: 33371817)
1. Gossypol Reduces Metastasis and Epithelial-Mesenchymal Transition by Targeting Protease in Human Cervical Cancer.
Hsieh YS; Chu SC; Huang SC; Kao SH; Lin MS; Chen PN
Am J Chin Med; 2021; 49(1):181-198. PubMed ID: 33371817
[TBL] [Abstract][Full Text] [Related]
2. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells.
Chu SC; Yu CC; Hsu LS; Chen KS; Su MY; Chen PN
Mol Pharmacol; 2014 Dec; 86(6):609-23. PubMed ID: 25217495
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effects of gossypol on colon cancer cells by targeting the u-PA and FAK pathways.
Huang SF; Chu SC; Hsu LS; Tu YC; Chen PN; Hsieh YS
Food Funct; 2019 Dec; 10(12):8172-8181. PubMed ID: 31730141
[TBL] [Abstract][Full Text] [Related]
4. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Hsiao YH; Hsieh MJ; Yang SF; Chen SP; Tsai WC; Chen PN
Phytomedicine; 2019 Sep; 62():152964. PubMed ID: 31153059
[TBL] [Abstract][Full Text] [Related]
5. Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells.
Hsieh YS; Chu SC; Hsu LS; Chen KS; Lai MT; Yeh CH; Chen PN
Food Chem Toxicol; 2013 Dec; 62():908-18. PubMed ID: 24161487
[TBL] [Abstract][Full Text] [Related]
6. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway.
Liu P; Pei JJ; Li L; Li JW; Ke XP
Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844
[TBL] [Abstract][Full Text] [Related]
9. Cinnamomum cassia extracts reverses TGF-β1-induced epithelial-mesenchymal transition in human lung adenocarcinoma cells and suppresses tumor growth in vivo.
Lin CY; Hsieh YH; Yang SF; Chu SC; Chen PN; Hsieh YS
Environ Toxicol; 2017 Jul; 32(7):1878-1887. PubMed ID: 28258635
[TBL] [Abstract][Full Text] [Related]
10. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
Tyszka-Czochara M; Lasota M; Majka M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
12. Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition.
Chen PN; Yang SF; Yu CC; Lin CY; Huang SH; Chu SC; Hsieh YS
Environ Toxicol; 2017 Aug; 32(8):2053-2063. PubMed ID: 28371048
[TBL] [Abstract][Full Text] [Related]
13. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
14. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo.
Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN
Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
Zhang L; Zhou J; Qin X; Huang H; Nie C
Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic effects of Celastrus orbiculatus on human gastric adenocarcinoma by inhibiting epithelial-mesenchymal transition and NF-κB/snail signaling pathway.
Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
Integr Cancer Ther; 2015 May; 14(3):271-81. PubMed ID: 25722220
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
18. Epicatechin-3-gallate reverses TGF-β1-induced epithelial-to-mesenchymal transition and inhibits cell invasion and protease activities in human lung cancer cells.
Huang SF; Horng CT; Hsieh YS; Hsieh YH; Chu SC; Chen PN
Food Chem Toxicol; 2016 Aug; 94():1-10. PubMed ID: 27224248
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
20. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
